Global Dry Eye Syndrome Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Dry Eye Syndrome Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Dry Eye Syndrome market size was valued at US$ 5811 million in 2024 and is forecast to a readjusted size of USD 7827 million by 2031 with a CAGR of 4.4% during review period.

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

In this report, we mainly study the drugs and eye drops for dry eye.

Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.

North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.

In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.

This report is a detailed and comprehensive analysis for global Dry Eye Syndrome market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Dry Eye Syndrome market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Dry Eye Syndrome market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Dry Eye Syndrome market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Dry Eye Syndrome market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Dry Eye Syndrome

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Dry Eye Syndrome market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Dry Eye Syndrome market is split by Type and by Distribution Channel. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Artificial Tears
Anti-inflammatory Drugs
Others

Market segment by Distribution Channel
Hospital
Retail Pharmacy
Others

Major players covered
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Dry Eye Syndrome product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Dry Eye Syndrome, with price, sales quantity, revenue, and global market share of Dry Eye Syndrome from 2020 to 2025.

Chapter 3, the Dry Eye Syndrome competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Dry Eye Syndrome breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Distribution Channel, with sales market share and growth rate by Type, by Distribution Channel, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dry Eye Syndrome market forecast, by regions, by Type, and by Distribution Channel, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Eye Syndrome.

Chapter 14 and 15, to describe Dry Eye Syndrome sales channel, distributors, customers, research findings and conclusion.